Skip to main content
. 2018 Mar 30;170(3):487–497. doi: 10.1007/s10549-018-4768-0

Table 1.

Characteristics of study participants in a nested biopsy study within the Karolinska mammography project for risk prediction for breast cancer (Karma) (N = 153)

Characteristics or histological markers N Mean (SD), range, or number (%)
Characteristic
 Age at biopsy (y) 153 57.2 (9.0), 41–76
 BMI (Kg/m2) 151 25.5 (4.4), 18.9–44.8
 Age at menarche (y) 145 13.1 (1.4), 9–17
 Age at first birth (y) 126 26.3 (5.2), 17–46
 Age at menopause (y) 79 50.6 (4.7), 35–59
 Parous status 146
  Nulliparous 20 (13.7)
  Parous 126 (86.3)
 Pregnancies (number) 146 2.4 (1.6), 0–8
 Births (number) 146 1.8 (1.1), 0–5
 Breastfeeding (months)a 125 17.1 (10.1), 0–53
 Ever taken oral contraceptives 144
  No 24 (16.7)
  Yes 120 (83.3)
 Postmenopausal status 150
  Premenopausal 55 (36.7)
  Postmenopausal 95 (63.3)
 Ever taken hormone replacement therapy 148
  No 106 (71.6)
  Yes 42 (28.4)
 Benign breast disorder 151
  No 111 (73.5)
  Yes 40 (26.5)
Tissue distribution and proteins markers
 Epithelial area (%) 153 3.7 (6.0), 0.0–34.2
 Stromal area (%) 153 45.9 (28.9), 1.6–100
 Adipose area (%) 153 50.4 (30.9), 0.0–98.4
 Epithelial Ki-67 (%) 111 2.4 (2.6), 0.0–17.0
 Epithelial ER (%) 110 30.4 (11.2), 4–56.8
 Epithelial PR (%) 114 16.1 (12.9), 0–57.9
 Stromal Ki-67 112
  Negative 78 (69.6)
  Positive 34 (30.4)
 Stromal ER 112
  Negative 22 (19.6)
  Positive 90 (80.4)
 Stromal PR 122
  Negative 20 (16.4)
  Positive 102 (83.6)

BMI body mass index, ER oestrogen receptor, IHC immunohistochemical, PR progesterone receptor, SD standard deviation, y years

aMinimum total duration of breastfeeding (months)